Pinealon
Pinealon is a lab-made peptide of just three amino acids, Glu-Asp-Arg, also called the EDR peptide. It is studied mainly in animal and cell work on brain aging, memory and protection of nerve cells.
At a glance
- Bioregulator
- oral, subcutaneous
- Not yet audited here; the reference library calls it emerging
- 1 mg per Peptide Dosing Protocols. See the source
- 20 mg in 3 mL
How much to draw
Full calculator →Opened on 1 mg, the figure Peptide Dosing Protocols reports for Pinealon, and a 20 mg vial in 3 mL. A reported amount, not a recommendation. Change any number to match the vial in your hand. How to reconstitute a vial.
What sources report
These are figures published elsewhere, reproduced with their source. Peppersite does not recommend an amount for Pinealon or for anything else, and nothing below has been checked against the study it came from.
| Amount | Frequency | Route | Reported by |
|---|---|---|---|
| Standard: 1.0 to 2.0 mg per day · Low: 1.0 mg · High: 2.0 mg | Once daily10 to 20 days · 2 to 3 cycles per year | subcutaneous injection or oral | Peptide Dosing ProtocolsWhat it saysHidePinealon is typically dosed at 1.0 to 2.0 mg per day. |
- Once daily10 to 20 days · 2 to 3 cycles per year
- subcutaneous injection or oral
- Peptide Dosing Protocols
What it saysHide
Pinealon is typically dosed at 1.0 to 2.0 mg per day.
- 3.0 mL BAC water
We have not published an audit on Pinealon. Everything below is reference material, not our own reading of the literature, treat it as a starting point for questions, not as a grade.
How it is thought to work
Pinealon is small enough that researchers think it can pass through cell membranes and into the nucleus, where it may help switch certain genes on or off. The genes named are ones tied to antioxidant defence and nerve-cell survival. Researchers call this epigenetic regulation through binding to gene promoter regions. The idea rests on animal and cell work, has not been confirmed in large human trials, and has seen thin independent replication outside the group that proposed it.
Pinealon is believed to help brain cells manage oxidative stress and support cognitive functions, although these effects are still experimental and not proven in large human trials. [Source: Peptide Dosing Protocols]
Reported side effects
Reported by users: mild headache, especially early in a course; sleep changes such as vivid dreams or lighter or deeper sleep in the first week; mild stomach and bowel effects with the oral capsules; and redness or itching at the injection site when it is injected.
Not ruled out: an allergic reaction is possible with any peptide. The effects of repeated courses over time have not been mapped in published Western trials. Because Pinealon acts on caspase-3 signalling, cancer-related risk has been neither ruled in nor out. Material sold under research-use labels varies in purity, sequence identity and contamination from supplier to supplier, and there is no validated lab marker for tracking it outside formal research.
Who should avoid it
People who are pregnant or breastfeeding: safety has not been established.
People with active cancer or a recent cancer history: Pinealon affects apoptosis and caspase-3 signalling, which has been linked both to suppressing tumours and, in some settings, to supporting them.
People with seizure disorders: any compound acting on the central nervous system is approached cautiously in this group.
Children and teenagers: no safety data exists for them.
People taking prescription central nervous system medicines: interactions have not been formally mapped.
People with known peptide allergies: a prior reaction to any short peptide is given as a reason to skip it.
Common questions
What is Pinealon?
Pinealon is a lab-made peptide of three amino acids, with the sequence Glu-Asp-Arg. It is also called the EDR peptide and was developed by a Russian research group.
Is Pinealon FDA-approved?
No. As of June 2026, Pinealon has no FDA-approved indication.
What amounts of Pinealon are reported in research?
Reported amounts and schedules for Pinealon differ by source, and peppersite does not recommend one. Each reported figure is listed in the dosing rows on this page, next to the source that reports it.
Can Pinealon be taken orally?
Yes. Published reports describe Pinealon given as oral capsules as well as by injection, and the most substantial human data comes from a small oral study in people recovering from traumatic brain injury.
How is Pinealon reconstituted?
That depends on the vial size and how much water is added. The calculator on this page works out the draw for any combination, and the reconstitution guide covers the steps.
How long is a typical Pinealon cycle?
Reported amounts and schedules for Pinealon differ by source, and peppersite does not recommend one. Each reported figure is listed in the dosing rows on this page, next to the source that reports it.
What supplies are needed for a Pinealon cycle?
Reported amounts and schedules for Pinealon differ by source, and peppersite does not recommend one. Each reported figure is listed in the dosing rows on this page, next to the source that reports it.
What are the main Pinealon side effects?
Reported effects include mild headache, sleep changes, stomach and bowel effects with capsules, and injection-site redness. The published record is thinner than for approved drugs, so this is what has been reported rather than what is known to be safe long term.
Sources
- 01Khavinson V, Ribakova Y, Kulebiakin K, et al. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation Research (2011)
- 02Kraskovskaya NA, Kukanova EO, Lin'kova NS, Popugaeva EA, Khavinson VKh. Tripeptides Restore the Number of Neuronal Spines under Conditions of In Vitro Modeled Alzheimer's Disease. Bulletin of Experimental Biology and Medicine (2017)
- 03Khavinson VKh, Lin'kova NS, Kvetnoy IM, et al. EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease. Molecules (MDPI) (2021)
- 04Arutjunyan A, Kozina L, Stvolinskiy S, et al. Pinealon protects the rat offspring from prenatal hyperhomocysteinemia. International Journal of Clinical and Experimental Medicine (2012)
- 05Karantysh GV, Mendzheritskii AM, Ryzhak GA, et al. Effect of Pinealon on Learning and Expression of NMDA Receptor Subunit Genes in the Hippocampus of Rats with Experimental Diabetes. Neurochemical Journal (2020)
- 06Khavinson VKh, Tarnovskaya SI, Lin'kova NS, et al. Short Peptides and Telomere Length Regulator Hormone Irisin. Bulletin of Experimental Biology and Medicine (2016)
- 07Khavinson VKh, Lin'kova NS, Umnov RS. Peptide KED: Molecular-Genetic Aspects of Neurogenesis Regulation in Alzheimer's Disease. Bulletin of Experimental Biology and Medicine (2021)
- 08Meshchaninov VN, Tkachenko EL, Zharkov SV, et al. Effect of synthetic peptides on aging of patients with chronic polymorbidity and organic brain syndrome of the central nervous system in remission. Advances in Gerontology (2015)
- 09National Center for Biotechnology Information. PubChem Compound Summary for CID 10273502, Pinealon (Glu-Asp-Arg). PubChem (2026)
- 10U.S. Food and Drug Administration. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (Category 1 list). FDA.gov (2026)
The reference sections on this page come from a compound library we import, not from our own review of the studies. Our own evidence grade appears only where an audit is linked. Research use only; nothing here is medical advice or a protocol.
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small lab-made molecule, not a true peptide, though it is often sold alongside research peptides. It is studied for shrinking fat cells and raising NAD+ levels, and all evidence so far comes from cell and rodent studies, with no published human trial.
BPC-157 (Body Protection Compound 157) is a lab-made chain of 15 amino acids based on a sequence first found in human gastric juice. It is mostly studied in animal models of tendon, ligament, gut and blood-vessel injury, and human evidence is limited to three small pilots.
Cerluten is an oral peptide bioregulator referenced for nervous system support. Its proposed action, tissue-specific peptide bioregulation, is described as theoretical.
CJC-1295 with DAC is a lab-made 30-amino-acid copy of growth hormone-releasing hormone, altered so it attaches to albumin, a protein in the blood. It was studied in early human trials for its effect on growth hormone and IGF-1 levels.
This is a combination research blend sold as one vial: CJC-1295 without DAC, a copy of growth hormone-releasing hormone, plus Ipamorelin, a short peptide that acts on the ghrelin receptor. It is studied as a GHRH and GHRP pairing in growth-hormone research.
Endoluten is a peptide bioregulator taken by mouth, listed in the reference library as pineal support. Its proposed action, tissue-specific peptide bioregulation, is described as theoretical.